Prudential Financial Inc Ultragenyx Pharmaceutical Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 35,937 shares of RARE stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,937

Holding current value

$1.71 Million

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.21 - $59.36 $1.45 Million - $2.13 Million	35,937 New	35,937 $2 Million
Q3 2023 Nov 13, 2023	SELL	$34.92 - $46.66 $156,476 - $209,083	-4,481 Reduced 41.15%	6,409 $228,000
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $161,986 - $226,174	4,337 Added 66.18%	10,890 $502,000
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $242,395 - $319,196	6,553 New	6,553 $262,000
Q3 2022 Nov 04, 2022	SELL	$39.96 - $66.14 $976,822 - $1.62 Million	-24,445 Reduced 74.45%	8,390 $348,000
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $1.29 Million - $2.4 Million	-28,100 Reduced 46.11%	32,835 $1.96 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $3.44 Million - $4.67 Million	55,320 Added 985.22%	60,935 $4.43 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $1.11 Million - $1.33 Million	-15,100 Reduced 72.89%	5,615 $472,000
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $5.56 Million - $7.3 Million	-71,314 Reduced 77.49%	20,715 $1.87 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $4.09 Million - $5.14 Million	-44,419 Reduced 32.55%	92,029 $8.78 Million
Q1 2021 May 12, 2021	SELL	$106.9 - $167.73 $1.09 Million - $1.7 Million	-10,155 Reduced 6.93%	136,448 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $12.3 Million - $25.9 Million	146,146 Added 31979.43%	146,603 $20.3 Million
Q3 2020 Aug 05, 2021	SELL	$72.98 - $90.0 $10.1 Million - $12.4 Million	-137,923 Reduced 99.67%	457 $38,000
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $8.59 Million - $10.6 Million	117,701 Added 569.18%	138,380 $11.4 Million
Q2 2020 Aug 12, 2020	SELL	$46.91 - $78.22 $2.37 Million - $3.95 Million	-50,541 Reduced 70.96%	20,679 $1.62 Million
Q1 2020 May 12, 2020	BUY	$33.8 - $62.9 $1.66 Million - $3.08 Million	48,970 Added 220.09%	71,220 $3.16 Million
Q4 2019 Feb 11, 2020	BUY	$36.08 - $45.83 $618,411 - $785,526	17,140 Added 335.42%	22,250 $950,000
Q2 2019 Aug 08, 2019	BUY	$54.93 - $74.36 $7,140 - $9,666	130 Added 2.61%	5,110 $0
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $23,922 - $41,616	600 Added 13.7%	4,980 $0
Q2 2018 Aug 13, 2018	BUY	$48.54 - $85.31 $12,135 - $21,327	250 Added 6.05%	4,380 $0
Q1 2018 May 04, 2018	SELL	$44.33 - $58.52 $1.16 Million - $1.53 Million	-26,204 Reduced 86.38%	4,130 $0
Q4 2017 Feb 13, 2018	BUY	$43.54 - $57.32 $548,342 - $721,888	12,594 Added 70.99%	30,334 $1.41 Million
Q3 2017 Nov 02, 2017	BUY	$49.79 - $66.32 $883,274 - $1.18 Million	17,740	17,740 $945,000

Others Institutions Holding RARE

# of Institutions

322

Shares Held

85.5M

Call Options Held

668K

Put Options Held

288K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.34B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Ultragenyx Pharmaceutical Inc. Transaction History